Immune checkpoint inhibitor-associated toxicity in advanced non-small cell lung cancer: An updated understanding of risk factors

Immune checkpoint inhibitors (ICIs), such as programmed death-1 (PD-1), programmed death-ligand 1 (PD-L1), cytotoxic T lymphocyte antigen 4 (CTLA-4) antibodies, etc, have revolutionized cancer treatment strategies, including non-small cell lung cancer (NSCLC). While these immunotherapy agents have a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xiangxiao, Wang, Lina, Shang, Bin, Wang, Junren, Sun, Jian, Liang, Bin, Su, Lili, You, Wenjie, Jiang, Shujuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025397/
https://www.ncbi.nlm.nih.gov/pubmed/36949956
http://dx.doi.org/10.3389/fimmu.2023.1094414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025397/
https://www.ncbi.nlm.nih.gov/pubmed/36949956
http://dx.doi.org/10.3389/fimmu.2023.1094414

Ejemplares similares